To Observe the Efficacy and Safety by Comparing Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With Radical Resection Versus Chemotherapy Alone in Advanced Gastric Cancer With Single Non-curable Factor.
Gastrectomy Plus Chemotherapy Versus Chemotherapy Alone for Advanced Gastric Cancer With a Single Non-curable Factor
Sponsor: Shanghai Zhongshan Hospital
A observational or N/A phase clinical study on Gastric Cancer, this trial is ongoing. The trial is conducted by Shanghai Zhongshan Hospital and has accumulated 8 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2024 — Jul 2024 [monthly]
Unknown Status
Status: Enrolling By Invitation → Unknown Status
-
Jun 2022 — Jan 2024 [monthly]
Enrolling By Invitation
Status: Unknown Status → Enrolling By Invitation · Phase: PHASE3 → None
-
Mar 2022 — Jun 2022 [monthly]
Unknown Status PHASE3
Status: Enrolling By Invitation → Unknown Status
▶ Show 3 earlier versions
-
Jan 2021 — Mar 2022 [monthly]
Enrolling By Invitation PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Enrolling By Invitation PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Enrolling By Invitation PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Shanghai Zhongshan Hospital
For direct contact, visit the study record on ClinicalTrials.gov .